Cargando...
Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma
The treatment paradigm for advanced and metastatic renal cell carcinoma (mRCC) has evolved rapidly since the arrival of targeted therapies and novel immunotherapies. mRCC was previously treated only with cytokines. However, discoveries of mutations affecting the von Hippel-Lindau tumor suppressor ge...
Guardado en:
| Publicado en: | Am Soc Clin Oncol Educ Book |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855178/ https://ncbi.nlm.nih.gov/pubmed/28561652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_174469 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|